Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial ResultsĀ and Updates 2020 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Inspire Medical Systems (INSP) PT Raised to $50 at Oppenheimer
August 5, 2020 7:08 AM EDTOppenheimer analyst Suraj Kalia raised the price target on Inspire Medical Systems (NYSE: INSP) to $50.00 (from $42.00) while maintaining a Underperform rating.
The analyst commented, "Inspire reported 2Q revenues/GAAP EPS of $12.2M/($0.88), behind our estimates of $14.1M/($0.79), but ahead of consensus of $7.9M/($1.07)E,... More
Inspire Medical Systems (INSP) Tops Q2 EPS by 22c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
August 4, 2020 5:42 PM EDTInspire Medical Systems (NYSE: INSP) reported Q2 EPS of ($0.88), $0.22 better than the analyst estimate of ($1.10). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $7.85 million.
Recent Business Highlights
Generated revenue of $12.2 million in the second quarter of 2020, a 32% decrease over the same quarter last yearActivated 16 new U.S. medical centers in the second quarter of 2020Created nine new territories in the second quarter of 2020, bringing the total to 91 U.S. territoriesAnnounced that all seven Medicare Administrative Contractors' ("MACs") final Local Coverage Determinations ("LCDs") became... More
